Today: 9 June 2026
Browse Category

NASDAQ:VIAV 30 October 2025 - 20 May 2026

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
20 May 2026
·
Viavi Solutions stock price jumps nearly 16% as Q2 beat and upbeat outlook collide with job-cut plan

Viavi Solutions stock price jumps nearly 16% as Q2 beat and upbeat outlook collide with job-cut plan

Viavi Solutions shares jumped nearly 16% Thursday after reporting quarterly revenue of $369.3 million, up 36.4%, and adjusted EPS of 22 cents, beating forecasts. The company raised March quarter guidance above analyst estimates and announced a restructuring plan affecting 5% of staff. Trading volume topped 9 million shares. UBS and B. Riley raised price targets following the report.
29 January 2026
··
Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

Applied Optoelectronics shares jumped nearly 18% to $44.05 midday after Oxford Instruments announced a plasma equipment supply deal for AOI’s Texas facility. The agreement supports AOI’s expansion in indium phosphide production for optical transceivers used in AI data centers. Investors also watched the Fed’s policy decision for its impact on tech stocks.
28 January 2026
······
Viavi Solutions (VIAV) stock slides 8% as it unveils Verizon-linked AR tool — what’s next

Viavi Solutions (VIAV) stock slides 8% as it unveils Verizon-linked AR tool — what’s next

Viavi Solutions shares dropped 8% to $17.03 Thursday afternoon, with 3 million shares traded after hitting a session low of $16.98. The decline followed a broader tech selloff as investors digested new labor data and anticipated Friday’s U.S. jobs report. Keysight Technologies shares also fell about 3%. Earlier, Viavi announced integration of its RF Viewer tool with the OneAdvisor 800 platform in partnership with Verizon.
8 January 2026
···
Viavi Stock Skyrockets on Blowout Earnings, AI Data-Center Boom

Viavi Stock Skyrockets on Blowout Earnings, AI Data-Center Boom

Viavi shares jumped 21% to $16.92 on Oct. 30, hitting a multi-year high with trading volume over 10.7 million. Fiscal Q1 revenue rose 25.6% to $299.1 million, beating estimates; non-GAAP EPS reached $0.15. Management guided Q2 revenue to $360–370 million, well above analyst forecasts. The company closed a $425 million acquisition of Spirent’s Ethernet and network-security testing business on Oct. 16.
30 October 2025
····

Stock Market Today

  • Nuvalent Shares Surge Near $124 Following GSK's $10.6 Billion Buyout Offer
    June 9, 2026, 10:35 AM EDT. Nuvalent's stock jumped 38.9% to $122.93 after GSK announced a $10.6 billion cash acquisition at $124 per share, reflecting a 40% premium to the last close. The deal highlights GSK's strategic move to expand its oncology portfolio beyond its current 6% share of sales, aiming to capitalize on Nuvalent's two lung cancer drugs pending FDA decisions this year. The tender offer needs the approval of at least half of Nuvalent's Class A shares and U.S. antitrust clearance. Early analyst reactions included target price adjustments but echoed caution over valuation. Nuvalent's pipeline products could face competition from existing ALK-targeted therapies by Pfizer and Roche.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Go toTop